Da An Gene's subsidiary receives CNY 348,600 cash dividend
Da An Gene (SZSE:002030) announced that its wholly-owned subsidiary, Da An Technology, received a CNY 348,600 cash dividend from Guangzhou AnBiPing Medical Technology. The dividend stems from AnBiPing's 2024 annual shareholder meeting, where a distribution of CNY 0.10 per share was approved, based on a total share capital of 93,567,699 shares, resulting in a total dividend payout of CNY 9,356,769.90. Da An Technology holds approximately 3.73% of AnBiPing. This dividend income will increase Da An Gene's 2025 consolidated net profit by CNY 348,600.00. The announcement was made on May 29, 2025.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
News Alerts
Get instant email alerts when Da An Gene Of Sun Yat-Sen University publishes news
Free account required • Unsubscribe anytime